Dysentery disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: DYS015 MIFTS: 45	Dysentery Categories: Gastrointestinal diseases
Genes Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs Expand all tables

Sources

Aliases & Classifications for Dysentery

MalaCards integrated aliases for Dysentery:

Name: Dysentery ¹² ⁴⁵ ¹⁵ ¹⁷ ⁷⁴

Infectious Diarrhea ¹² ⁵⁶ ⁶⁴

Classifications:

MalaCards categories:
Anatomical: Gastrointestinal diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology ¹² DOID:12384

ICD9CM ³⁶ 009.2

MeSH ⁴⁵ D004403

SNOMED-CT ⁶⁹ 19213003

EFO ¹⁷ EFO_1001869

UMLS ⁷⁴ C0013369

Sources

Summaries for Dysentery

PubMed Health : ⁶⁴ About infectious diarrhea: Diarrhea is very common: In Germany, for instance, adults get it once a year on average, and it is even more common in children. It is usually caused by viruses, the most common of which are the highly contagious norovirus and rotavirus. Infectious diarrhea can also come from bacteria such as Salmonella or Campylobacter.In normal cases of diarrhea, you can usually just replace the fluids you lose and wait until the infection goes away. But more severe or longer lasting diarrhea needs to be treated because it can lead to the loss of dangerously high levels of fluid and salt, especially in young children and older people.

MalaCards based summary : Dysentery, also known as infectious diarrhea, is related to paratyphoid fever and abdominal tuberculosis, and has symptoms including diarrhea An important gene associated with Dysentery is ALB (Albumin), and among its related pathways/superpathways is Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways. The drugs Ciprofloxacin and Omeprazole have been mentioned in the context of this disorder. Affiliated tissues include colon, liver and testes.

Disease Ontology : ¹² An intestinal infectious disease that involves inflammation of the intestines, especially colon, due to chemical irritants, bacteria, protozoa, or parasitic worms, which results in severe diarrhea with passage of mucus and blood.

Wikipedia : ⁷⁷ Dysentery is an inflammatory disease of the intestine, especially of the colon, which always results in... more...

Sources

Related Diseases for Dysentery

Diseases related to Dysentery via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 174)

#	Related Disease	Score	Top Affiliating Genes
1	paratyphoid fever	30.4	CRP IL1A
2	abdominal tuberculosis	30.4	ALB CRP
3	appendicitis	30.3	ALB CRP ENO2
4	malaria	30.2	ALB CRP HP IL1A TF
5	deficiency anemia	30.0	ALB CRP HP TF
6	urethritis	29.9	MRAP PHB2
7	enthesopathy	29.7	MRAP PHB2
8	protozoal dysentery	12.4
9	amebiasis	12.2
10	balantidiasis	11.7
11	shigellosis	11.7
12	campylobacteriosis	11.2
13	oesophagostomiasis	11.1
14	diarrhea	10.6
15	colitis	10.5
16	epstein-barr virus hepatitis	10.5	ALB TF
17	cholera	10.5
18	gastrointestinal tuberculosis	10.4	ALB CRP
19	yellow nail syndrome	10.4	ALB TF
20	folic acid deficiency anemia	10.4	CRP TF
21	paramyloidosis	10.4	ALB TTR
22	acquired angioedema	10.4	CRP HP
23	keratomalacia	10.4	TF TTR
24	median rhomboid glossitis	10.4	TF TTR
25	melancholia	10.4	HP TF
26	burns	10.4	ALB TTR
27	bronchus cancer	10.4	CRP ENO2
28	granulomatous hepatitis	10.4	CRP IFNA2
29	congenital disorder of glycosylation, type ia	10.4	HP TF
30	aleutian mink disease	10.4	ALB TTR
31	tuberculous peritonitis	10.4	ALB CRP
32	chronic ulcer of skin	10.3	ALB TTR
33	amyloidosis aa	10.3	CRP TTR
34	thyroid crisis	10.3	ALB TTR
35	ulcerative colitis	10.3
36	rheumatic myocarditis	10.3	CRP IL1A
37	chronic graft versus host disease	10.3	ALB IL1A
38	hyperthyroxinemia	10.3	ALB TTR
39	pericardium disease	10.3	ALB CRP
40	blind loop syndrome	10.3	ALB TTR
41	iron overload in africa	10.3	HP TF
42	chronic pulmonary heart disease	10.3	HP TTR
43	end stage renal failure	10.3	ALB CRP TF
44	uremia	10.3	ALB CRP TF
45	pure red-cell aplasia	10.3	ALB TF
46	urinary system disease	10.3	ALB CRP TF
47	marasmus	10.3	ALB TF TTR
48	kwashiorkor	10.3	ALB TF TTR
49	ariboflavinosis	10.3	ALB TF
50	gastroenteritis	10.3

Comorbidity relations with Dysentery via Phenotypic Disease Network (PDN):

Acute Cystitis

Graphical network of the top 20 diseases related to Dysentery:

Sources

Symptoms & Phenotypes for Dysentery

UMLS symptoms related to Dysentery:

diarrhea

Sources

Drugs & Therapeutics for Dysentery

PubMedHealth treatment related to Dysentery: ⁶⁴

You lose fluids and electrolytes when you have diarrhea, so it is important to replace them. For acute, non-severe diarrhea you usually just need something like tea with sugar and some salted crackers. Foods that are gentle on the stomach is recommended too, such as rice, bananas or rusk bread. Some people also avoid coffee, fruit juices, sodas, alcohol and fatty foods to keep from irritating their bowel even more.Acute, non-severe diarrhea does not require special treatment in adults and teenagers. But it is a good idea for young children and older people, as well as people with more severe diarrhea, to replace fluids and electrolytes by using oral rehydration salts (electrolyte/glucose solutions) from the pharmacy. These are powders containing salts, minerals and glucose that can be dissolved in water. If these solutions are not available (for instance, while traveling) the following ingredients can be stirred into one liter of bottled or boiled water:Five tablespoons of sugarOne and a half level tablespoons of saltOne glass of packaged orange juiceIn addition to drinking fluids and using other treatments, foods or dietary supplements that have probiotic microorganisms (probiotics) in them can help to make the diarrhea go away faster.Depending on how severe the symptoms are and how long they last, other treatments may be considered too:Drugs like loperamide or racecadotril can help to slow down the activity of the bowel and lower the number of times you need to go to the bathroom. Loperamide is not suitable for children under the age of twelve years, and racecadotril is prescription-only for children.Sometimes certain types of yeast tablets (Perenterol) are also recommended. These tablets are thought to help the body get rid of the germs faster and to support natural gut flora. Charcoal tablets dissolved in water can also be taken to relieve diarrhea symptoms. But there is a lack of good-quality research in this area so no conclusions can be drawn about the benefits and harms of these treatment options.Antibiotics are only an option if the infection is bacterial. They can't fight viruses.

Drugs for Dysentery (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 167)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Ciprofloxacin

Approved, Investigational

Phase 4,Phase 3,Phase 2

85721-33-1

2764

Omeprazole

Approved, Investigational, Vet_approved

Phase 4

73590-58-6

4594

Azithromycin

Approved

Phase 4,Phase 2,Phase 3,Not Applicable

83905-01-5

447043 55185

Loperamide

Approved

Phase 4,Phase 3,Not Applicable

53179-11-6

3955

Rifaximin

Approved, Investigational

Phase 4,Phase 2,Phase 3,Not Applicable

80621-81-4

46783403 6436173

Mebendazole

Approved, Vet_approved

Phase 4

31431-39-7

4030

Sodium Citrate

Approved, Investigational

Phase 4

68-04-2

Piperazine

Approved, Vet_approved

Phase 4

110-85-0

4837

Amoxicillin

Approved, Vet_approved

Phase 4

26787-78-0

33613

Citric Acid

Approved, Nutraceutical, Vet_approved

Phase 4

77-92-9

311

Acidophilus

Phase 4,Phase 3,Phase 1,Phase 2

Antibiotics, Antitubercular

Phase 4,Phase 2,Phase 3,Early Phase 1

Anti-Bacterial Agents

Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1

Anti-Infective Agents

Phase 4,Phase 2,Phase 3,Not Applicable

Antiparasitic Agents

Phase 4,Phase 3,Phase 2

Antitubercular Agents

Phase 4,Phase 3

Cytochrome P-450 Enzyme Inhibitors

Phase 4,Phase 3,Phase 2,Not Applicable

Topoisomerase Inhibitors

Phase 4,Phase 3,Phase 2,Not Applicable

Cytochrome P-450 CYP1A2 Inhibitors

Phase 4,Phase 3,Phase 2,Not Applicable

Antacids

Phase 4,Phase 1

Anti-Ulcer Agents

Phase 4,Phase 1

Cola

Phase 4,Not Applicable

Proton Pump Inhibitors

Phase 4

Gastrointestinal Agents

Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable

Antidiarrheals

Phase 4,Phase 3,Not Applicable

Antimitotic Agents

Phase 4

DMP 777

Phase 4

157341-41-8

Citrate

Phase 4

Piperazine citrate

Phase 4

Anthelmintics

Phase 4

Clavulanic Acids

Phase 4

beta-Lactamase Inhibitors

Phase 4

Amoxicillin-Potassium Clavulanate Combination

Phase 4

Fluoroquinolones

Phase 4

Iron

Approved, Experimental

Phase 3,Phase 2,Not Applicable

7439-89-6, 15438-31-0

27284 23925

Zinc sulfate

Approved, Investigational

Phase 3

7733-02-0

Zinc

Approved, Investigational

Phase 3,Phase 2,Not Applicable

7440-66-6

32051

leucovorin

Approved

Phase 3,Not Applicable

58-05-9

143 6006

Nitazoxanide

Approved, Investigational, Vet_approved

Phase 3,Phase 2

55981-09-4

41684

Terlipressin

Approved, Investigational

Phase 3

14636-12-5

72081

Lactulose

Approved

Phase 2, Phase 3

4618-18-2

11333

Irinotecan

Approved, Investigational

Phase 3

100286-90-6, 97682-44-5

60838

Folic Acid

Approved, Nutraceutical, Vet_approved

Phase 3,Not Applicable

59-30-3

6037

Vitamin A

Approved, Nutraceutical, Vet_approved

Phase 3,Not Applicable

68-26-8, 22737-96-8, 11103-57-4

9904001 445354

Rifamycins

Phase 3,Phase 2

rifamycin SV

Phase 3,Phase 2

Antirheumatic Agents

Phase 3,Phase 2,Phase 1

Immunoglobulins

Phase 3,Phase 1

Immunologic Factors

Phase 3,Phase 1,Phase 2

Antibodies

Phase 3,Phase 1

Interventional clinical trials:

(show top 50) (show all 111)

#	Name	Status	NCT ID	Phase	Drugs
1	Improving Bowel Habits of Elderly With Probiotics and Non-probiotics	Unknown status	NCT02949882	Phase 4
2	New Hypo-Osmolar ORS (Recommended by WHO) for Routine Use in the Diarrhea Management– Surveillance Study for Adverse Effects	Completed	NCT00490932	Phase 4	Hypo-osmolar ORS
3	Effects of Gastric Acid on Colonic Microbiome	Completed	NCT01901276	Phase 4	Omeprazole 40 mg bid
4	Azithromycin, With or Without Loperamide, to Treat Travelers' Diarrhea	Completed	NCT00359970	Phase 4	Azithromycin 500 mg;Azithromycin 1000 mg;Loperamide
5	Rifaximin, Loperamide and the Combination to Treat Travelers' Diarrhea	Completed	NCT00292344	Phase 4	Rifaximin and loperamide
6	Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population	Completed	NCT02385058	Phase 4	Mebendazole;Quinfamide;Placebo
7	Lactobacillus Reuteri DSM 17938 in the Prevention of Antibiotic-associated Diarrhea in Children: Protocol of a Randomized Controlled Trial	Completed	NCT02871908	Phase 4	Lactobacillus reuteri DSM 17938;Placebo
8	Effect of Lactobacillus Reuteri DSM 17938 to Prevent Antibiotic-associated Diarrhea in Children	Recruiting	NCT02765217	Phase 4	Lactobacillus reuteri DSM 17938;Placebo;Amoxicillin-Clavulanic Acid
9	Ciprofloxacin Versus Azithromycin for Children Hospitalised With Dysentery	Not yet recruiting	NCT03854929	Phase 4	Ciprofloxacin;Azithromycin
10	Study of Bio-K+® in the Reduction of the Risk of Clostridium Difficile Infection and Antibiotic Associated Diarrhea	Terminated	NCT01972932	Phase 4
11	Probiotics and the Prevention of Traveler's Diarrhea	Terminated	NCT01005849	Phase 4
12	Use of Bismuth Subsalicylate in Clostridium Difficile Colitis	Withdrawn	NCT03592082	Phase 4	Bismuth Subsalicylate;standard antibiotic therapy
13	Single Daily Dose Rifaximin for the Treatment of Travelers' Diarrhea	Withdrawn	NCT00875875	Phase 4	Rifaximin
14	Randomized Controlled Field Trial of a Probiotics to Assess Its Role in Preventig Diarrhoea	Unknown status	NCT00534170	Phase 3
15	Efficacy of Rifaximin in Preventing Campylobacteriosis	Completed	NCT02280044	Phase 2, Phase 3
16	Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea	Completed	NCT01208922	Phase 3	Rifamycin SV-MMX®;Ciprofloxacin
17	Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel	Completed	NCT00368316	Phase 3
18	Impact of Sprinkles on Infectious Morbidity When Moderate to Severe Pediatric Malnutrition Is Highly Prevalent	Completed	NCT00530374	Phase 3
19	Community Trial of Zinc Supplementation on Preschool Child Mortality and Morbidity in Southern Nepal	Completed	NCT00109551	Phase 3	zinc sulphate dietary supplement;iron sulphate-folic acid dietary supplement
20	Fermented Milk and Fermented Rice on the Appearance of Respiratory and Gastrointestinal Symptoms	Completed	NCT01909128	Phase 3
21	Vitamin A Supplementation in Newborns Study	Completed	NCT00114868	Phase 3	Vitamin A
22	Zinc Supplementation in Shigella Patients	Completed	NCT00321126	Phase 3	Children in the zinc group received 20 mg of elemental zinc as acetate per day in a twice-daily dose for two weeks.
23	Study of Nitazoxanide in the Treatment of Amebiasis in Children	Completed	NCT00366730	Phase 3	Nitazoxanide
24	Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents	Completed	NCT00366236	Phase 3	Nitazoxanide
25	Study to Evaluate Safety and Efficacy of Rifamycin SV Multi-Matrix System (MMX) for the Treatment of Traveler's Diarrhea (TD)	Completed	NCT01142089	Phase 3	Placebo;Rifamycin SV MMX
26	Travelers' Diarrhea (TD) Vaccine Pivotal Efficacy Study	Completed	NCT00993681	Phase 3
27	Rifaximin for Prevention of Travellers' Diarrhea	Completed	NCT00742469	Phase 3	Rifaximin;Placebo
28	Efficacy of BIO-K+ CL1285® Prophylaxis in the Prevention of Traveler's Diarrhea in Adults	Completed	NCT00737412	Phase 3
29	Prevention of Travelers' Diarrhea in Subjects Traveling Outside the U.S.	Completed	NCT00328380	Phase 3	Rifaximin
30	Complementary Food Supplements for Reducing Childhood Undernutrition	Completed	NCT01562379	Phase 2, Phase 3
31	Comparison of Bovine Colostrum Versus Placebo in Treatment of Severe Alcoholic Hepatitis: A Randomized Double Blind Controlled Trial	Recruiting	NCT02473341	Phase 3	Bovine Colostrum;Placebo
32	Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic Encephalopathy	Recruiting	NCT02464124	Phase 2, Phase 3	Nitazoxanide;Lactulose
33	Prevention of Irinotecan Induced Diarrhea by Probiotics	Recruiting	NCT02819960	Phase 3	PROBIO-FIX INUM®;Placebo
34	Protein Plus: Improving Infant Growth Through Diet and Enteric Health	Recruiting	NCT03683667	Phase 2, Phase 3	Azithromycin Oral Product;Placebos
35	A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea.	Terminated	NCT02920242	Phase 3	Rifaximin (Sandoz GmbH) tablet;Rifaximin (Xifaxan);Placebo
36	A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea	Terminated	NCT00466635	Phase 3	GT267-004 (tolevamer potassium sodium)
37	Clinical Trial of CBS-2004 in Prevention of Travelers' Diarrhea	Withdrawn	NCT02736539	Phase 3	CBS 2004 (galacto-oligosaccharides);Placebo
38	A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in Humans	Unknown status	NCT01243437	Phase 2	ciprofloxacin;doxyxcycline
39	Efficacy and Safety of CB-01-11 200mg Tablets in Infectious Diarrhoea	Completed	NCT03447821	Phase 2	400 mg Rifamycin SV dosage;800 mg Rifamycin SV dosage;1200 mg Rifamycin SV dosage
40	Probiotics for Infectious Diarrhea in Children in South India	Completed	NCT01130792	Phase 1, Phase 2
41	Isoleucine Added ORS in Children With Diarrhoea	Completed	NCT01034228	Phase 2
42	Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate	Completed	NCT01080716	Phase 1, Phase 2
43	Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection	Completed	NCT00485134	Phase 1, Phase 2
44	Effect of Irvingia Gabonensis Administration on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity	Completed	NCT02354339	Phase 2
45	A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults	Completed	NCT02676895	Phase 2
46	Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a	Completed	NCT02646371	Phase 2
47	Therapeutic Induction of Endogenous Antibiotics	Completed	NCT00800930	Phase 2
48	Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine	Completed	NCT00210288	Phase 2
49	Efficacy of Combination Therapy of Glucocorticoids and Bovine Colostrum in Treatment of Severe Alcoholic Hepatitis.	Completed	NCT02265328	Phase 2
50	Traveler's Diarrhea (TD) Vaccine Asia Efficacy Study	Completed	NCT01040325	Phase 2

Search NIH Clinical Center for Dysentery

Inferred drug relations via UMLS ⁷⁴ / NDF-RT ⁵² :

ciprofloxacin

scopolamine

scopolamine hydrobromide

Cochrane evidence based reviews: dysentery

Sources

Genetic Tests for Dysentery

Sources

Anatomical Context for Dysentery

MalaCards organs/tissues related to Dysentery:

⁴²

Colon, Liver, Testes, Bone, Kidney, Spleen, Bone Marrow

Sources

Publications for Dysentery

Articles related to Dysentery:

(show top 50) (show all 2079)

#	Title	Authors	Year
1	Association of meteorological factors with infectious diarrhea incidence in Guangzhou, southern China: A time-series study (2006-2017). ( 30954825 )	Wang H...Yang Z	2019
2	Critical role of bacterial dissemination in an infant rabbit model of bacillary dysentery. ( 31015451 )	Yum LK...Agaisse H	2019
3	Modelling the dynamics of direct and pathogens-induced dysentery diarrhoea epidemic with controls. ( 30843764 )	Berhe HW...Theuri DM	2019
4	Effect of ambient temperature and its effect modifiers on bacillary dysentery in Jinan, China. ( 30373074 )	Liu Z...Jiang B	2019
5	Chemical composition of Acacia farnesiana (L) wild fruits and its activity against Mycobacterium tuberculosis and dysentery bacteria. ( 30367988 )	Hern?ndez-Garc?a E...Del Rayo Camacho-Corona M	2019
6	Recent Prescription Patterns for Children With Acute Infectious Diarrhea. ( 30074577 )	Okubo Y...Yasunaga H	2019
7	Acute Infectious Diarrhea. ( 30649712 )	Lo Vecchio A...Guarino A	2019
8	Bovine colostrum and product intervention associated with relief of childhood infectious diarrhea. ( 30816291 )	Li J...Song QK	2019
9	Smectite for Acute Infectious Diarrhea in Children. ( 30811159 )	Smith DK...Sohn JD	2019
10	Diagnosis and Management of Infectious Diarrhea. ( 30763429 )	Hamilton KW...Cifu AS	2019
11	Diagnostic determination of Norovirus infection as one of the major causes of infectious diarrhea in HIV patients using a multiplex polymerase chain reaction assay. ( 30722749 )	Yang S...Hua W	2019
12	The impact of the 2016 flood event in Anhui Province, China on infectious diarrhea disease: An interrupted time-series study. ( 31051323 )	Zhang N...Huang C	2019
13	Diagnosing and tracing the pathogens of infantile infectious diarrhea by amplicon sequencing. ( 30992716 )	Liu H...Xu W	2019
14	Residential proximity to high-density poultry operations associated with campylobacteriosis and infectious diarrhea. ( 29268955 )	Poulsen MN...Schwartz BS	2018
15	Multiplex polymerase chain reaction test to diagnose infectious diarrhea in the emergency department. ( 30587396 )	Li A...Meltzer AC	2018
16	Origanum majorana L. extract exhibit positive cooperative effects on the main mechanisms involved in acute infectious diarrhea. ( 30217790 )	Makrane H...Eto B	2018
17	Long-Term Gastrointestinal Consequences are Frequent Following Sporadic Acute Infectious Diarrhea in a Tropical Country: A Prospective Cohort Study. ( 30171215 )	Rahman MM...Sarker SA	2018
18	Infectious Diarrhea: IDSA Updates Guidelines for Diagnosis and Management. ( 29763277 )	Randel A	2018
19	Diagnosis and Management of Infectious Diarrhea. ( 29889925 )	Parker MW...Unaka N	2018
20	Distribution and transmission of aetiological agents of swine dysentery. ( 30970310 )	David J H	2018
21	Spatiotemporal Characteristics of Bacillary Dysentery from 2005 to 2017 in Zhejiang Province, China. ( 30149494 )	Yan C...Cai J	2018
22	Identification of a New Antimicrobial Resistance Gene Provides Fresh Insights Into Pleuromutilin Resistance in Brachyspira hyodysenteriae, Aetiological Agent of Swine Dysentery. ( 29971045 )	Card RM...Anjum MF	2018
23	Guidelines for the treatment of dysentery (shigellosis): a systematic review of the evidence. ( 29790845 )	Williams PCM...Berkley JA	2018
24	Shigella Phages Isolated during a Dysentery Outbreak Reveal Uncommon Structures and Broad Species Diversity. ( 29437962 )	Doore SM...Parent KN	2018
25	Occurrence of dysentery-like diarrhoea associated with Brachyspira suanatina infection in a German fattening pig farm. ( 29419486 )	Rohde J...Stadler J	2018
26	Geraniol as a novel antivirulence agent against bacillary dysentery-causing Shigella sonnei. ( 29256316 )	Mirza ZRMH...Yu J	2018
27	Assessment on the burden of bacillary dysentery associated with floods during 2005-2009 in Zhengzhou City, China, using a time-series analysis. ( 29100875 )	Hu X...Ni W	2018
28	Assessing gut microbiota perturbations during the early phase of infectious diarrhea in Vietnamese children. ( 28767339 )	The HC...Baker S	2018
29	Effect of antibiotics for infectious diarrhea on the duration of hospitalization: A retrospective cohort study at a single center in Japan from 2012 to 2015. ( 28986192 )	Sasaki Y...Urita Y	2018
30	The other Campylobacters: Not innocent bystanders in endemic diarrhea and dysentery in children in low-income settings. ( 29415075 )	Fran?ois R...Kosek MN	2018
31	Association between floods and infectious diarrhea and their effect modifiers in Hunan province, China: A two-stage model. ( 29396332 )	Liu Z...Jiang B	2018
32	Challenges in developing mucosal vaccines and antibodies against infectious diarrhea in children. ( 29290097 )	Tokuhara D	2018
33	Serum procalcitonin levels can be used to differentiate between inflammatory and non-inflammatory diarrhea in acute infectious diarrhea. ( 30095641 )	Shin HJ...Lee BS	2018
34	Infectious diarrhea in autologous stem cell transplantation: high prevalence of coccidia in a South American center. ( 30057986 )	Castro MD...Neto AEH	2018
35	Time Series Analysis of the Microbiota of Children Suffering From Acute Infectious Diarrhea and Their Recovery After Treatment. ( 29946306 )	Dinleyici EC...Moya A	2018
36	The Role of Ion Transporters in the Pathophysiology of Infectious Diarrhea. ( 29928670 )	Das S...Barrett KE	2018
37	Chinese clinical practice guidelines for acute infectious diarrhea in children. ( 30269306 )	Chen J...Dong YS	2018
38	Use and Interpretation of Enteropathogen Multiplex Nucleic Acid Amplification Tests in Patients With Suspected Infectious Diarrhea. ( 30538605 )	Yalamanchili H...Okhuysen PC	2018
39	Gene Expression Levels of Peripheral Blood Mononuclear Cells IL-6 and TNF-α in Children with Bacterial and Viral Infectious Diarrhea. ( 30501830 )	Xu P...Liu X	2018
40	Empirical antibiotic treatment for children suffering from dysentery, cholera, pneumonia, sepsis or severe acute malnutrition. ( 29790843 )	Ashorn P	2018
41	Spatiotemporal Risk of Bacillary Dysentery and Sensitivity to Meteorological Factors in Hunan Province, China. ( 29286297 )	Xu C...Liang J	2017
42	An avirulent Brachyspira hyodysenteriae strain elicits intestinal IgA and slows down spread of swine dysentery. ( 28982389 )	Mahu M...Pasmans F	2017
43	Comparison of the Luminal and Mucosa-Associated Microbiota in the Colon of Pigs with and without Swine Dysentery. ( 28971100 )	Burrough ER...Plummer PJ	2017
44	Spatial-temporal detection of risk factors for bacillary dysentery in Beijing, Tianjin and Hebei, China. ( 28946856 )	Xu C...Xiao G	2017
45	An optimized swine dysentery murine model to characterize shedding and clinical disease associated with "Brachyspira hampsonii" infection. ( 28830508 )	Ek CE...Harding JCS	2017
46	Impact of meteorological factors on the incidence of bacillary dysentery in Beijing, China: A time series analysis (1970-2012). ( 28796834 )	Yan L...He J	2017
47	The dysentery epidemic in Poland in 1920-1921 ( 28742314 )	Wn?k J	2017
48	Environmental Drivers and Predicted Risk of Bacillary Dysentery in Southwest China. ( 28708077 )	Zhang H...Gong P	2017
49	Seasonal and geographical distribution of bacillary dysentery (shigellosis) and associated climate risk factors in Kon Tam Province in Vietnam from 1999 to 2013. ( 28637484 )	Lee HS...Nguyen-Viet H	2017
50	Projected burden of disease for bacillary dysentery due to flood events in Guangxi, China. ( 28605848 )	Liu X...Jiang B	2017

Sources

Genes for Dysentery

Genes related to Dysentery (0 elite genes):

(show all 15)

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence	PubmedIds
1	ALB	Albumin	Protein Coding	20.9	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
2	CRP	C-Reactive Protein	Protein Coding	20.61	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
3	TMPO	Thymopoietin	Protein Coding	20.42	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
4	TF	Transferrin	Protein Coding	20.36	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
5	HP	Haptoglobin	Protein Coding	20.22	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
6	TTR	Transthyretin	Protein Coding	20.22	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
7	ENO2	Enolase 2	Protein Coding	16.65	GeneCards inferred via : Publications (show sections)
8	IFNA2	Interferon Alpha 2	Protein Coding	16.65	GeneCards inferred via : Publications (show sections)
9	IL1A	Interleukin 1 Alpha	Protein Coding	16.65	GeneCards inferred via : Publications (show sections)
10	PHB2	Prohibitin 2	Protein Coding	15.66	DISEASES inferred ¹⁵
11	MFAP5	Microfibril Associated Protein 5	Protein Coding	15.59	DISEASES inferred ¹⁵
12	LTF	Lactotransferrin	Protein Coding	15.45	Novoseek inferred ⁵⁶	19028207
13	MRAP	Melanocortin 2 Receptor Accessory Protein	Protein Coding	15.04	DISEASES inferred ¹⁵
14	VIPR1	Vasoactive Intestinal Peptide Receptor 1	Protein Coding	15	DISEASES inferred ¹⁵
15	IL1RAPL2	Interleukin 1 Receptor Accessory Protein Like 2	Protein Coding	6.65	GeneCards inferred via : Publications (show sections)

Sources

Variations for Dysentery

Sources

Expression for Dysentery

Search GEO for disease gene expression data for Dysentery.

Sources

Pathways for Dysentery

Pathways related to Dysentery according to GeneCards Suite gene sharing:

#	Super pathways	Score	Top Affiliating Genes
1	Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways ¹	11.01	IL1A TF VIPR1

Sources

GO Terms for Dysentery

Cellular components related to Dysentery according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	extracellular region	GO:0005576	9.61	ALB CRP HP IFNA2 IL1A LTF
2	blood microparticle	GO:0072562	9.33	ALB HP TF
3	extracellular space	GO:0005615	9.28	ALB CRP ENO2 HP IFNA2 IL1A

Biological processes related to Dysentery according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	cellular protein metabolic process	GO:0044267	9.26	ALB LTF TF TTR
2	retina homeostasis	GO:0001895	8.8	ALB LTF TF

Molecular functions related to Dysentery according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	protein binding	GO:0005515	9.77	ALB CRP ENO2 HP IFNA2 IL1A
2	antioxidant activity	GO:0016209	8.62	ALB HP

Sources

Sources for Dysentery

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ EFO

¹⁸ ExPASy

¹⁹ FDA Approved Drugs

²⁰ FMA

²¹ GeneAnalytics

²² GeneCards

²³ GeneGo (Thomson Reuters)

²⁴ GeneHancer via GeneCards

²⁵ GeneReviews

²⁶ Genetics Home Reference

²⁷ GenomeRNAi

²⁸ GEO DataSets

²⁹ GO

³⁰ GTR

³¹ HGMD

³² HMDB

³³ HPO

³⁴ ICD10

³⁵ ICD10 via Orphanet

³⁶ ICD9CM

³⁷ IUPHAR

³⁸ KEGG

³⁹ LifeMap

⁴⁰ LncRNADisease

⁴¹ LOVD

⁴² MalaCards

⁴³ MedGen

⁴⁴ MedlinePlus

⁴⁵ MeSH

⁴⁶ MESH via Orphanet

⁴⁷ MGI

⁴⁸ miR2Disease

⁴⁹ NCBI Bookshelf

⁵⁰ NCI

⁵¹ NCIt

⁵² NDF-RT

⁵³ NIH Clinical Center

⁵⁴ NIH Rare Diseases

⁵⁵ NINDS

⁵⁶ Novoseek

⁵⁷ Novus Biologicals

⁵⁸ OMIM

⁵⁹ OMIM via Orphanet

⁶⁰ Orphanet

⁶¹ PathCards

⁶² PharmGKB

⁶³ PubMed

⁶⁴ PubMed Health

⁶⁵ QIAGEN

⁶⁶ R&D Systems

⁶⁷ Reactome

⁶⁸ Sino Biological

⁶⁹ SNOMED-CT

⁷⁰ SNOMED-CT via HPO

⁷¹ SNOMED-CT via Orphanet

⁷² TGDB

⁷³ Tocris

⁷⁴ UMLS

⁷⁵ UMLS via Orphanet

⁷⁶ UniProtKB/Swiss-Prot

⁷⁷ Wikipedia

Dysentery

Aliases & Classifications for Dysentery

MalaCards integrated aliases for Dysentery:

Classifications:

External Ids:

Summaries for Dysentery

Related Diseases for Dysentery

Diseases related to Dysentery via text searches within MalaCards or GeneCards Suite gene sharing:

Comorbidity relations with Dysentery via Phenotypic Disease Network (PDN):

Graphical network of the top 20 diseases related to Dysentery:

Symptoms & Phenotypes for Dysentery

UMLS symptoms related to Dysentery:

Drugs & Therapeutics for Dysentery

PubMedHealth treatment related to Dysentery: 64

Drugs for Dysentery (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

Interventional clinical trials:

Inferred drug relations via UMLS 74 / NDF-RT 52 :

Cochrane evidence based reviews: dysentery

Genetic Tests for Dysentery

Anatomical Context for Dysentery

MalaCards organs/tissues related to Dysentery:

Publications for Dysentery

Articles related to Dysentery:

Genes for Dysentery

Genes related to Dysentery (0 elite genes):

Variations for Dysentery

Expression for Dysentery

Pathways for Dysentery

Pathways related to Dysentery according to GeneCards Suite gene sharing:

GO Terms for Dysentery

Cellular components related to Dysentery according to GeneCards Suite gene sharing:

Biological processes related to Dysentery according to GeneCards Suite gene sharing:

Molecular functions related to Dysentery according to GeneCards Suite gene sharing:

Sources for Dysentery

PubMedHealth treatment related to Dysentery: ⁶⁴

Inferred drug relations via UMLS ⁷⁴ / NDF-RT ⁵² :